Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: indications diversity and future perspectives

A. Tzikas, T. Lewalter
{"title":"Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: indications diversity and future perspectives","authors":"A. Tzikas,&nbsp;T. Lewalter","doi":"10.1002/cce2.18","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Left atrial appendage occlusion (LAAO) is a promising alternative to oral anti-coagulation in patients with non-valvular atrial fibrillation. Recently, four-year results of PROTECT-AF demonstrated superiority of LAAO in all-cause mortality and stroke reduction compared to optimal medical treatment with warfarin. In this new era, it is important to identify the patients who would benefit more from LAAO and offer them priority for treatment.</p>\n <p><b>Answer questions and earn CME:</b> https://wileyhealthlearning.com/Activity2/4193475/Activity.aspx</p>\n </div>","PeriodicalId":100331,"journal":{"name":"Continuing Cardiology Education","volume":"2 1","pages":"32-36"},"PeriodicalIF":0.0000,"publicationDate":"2016-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/cce2.18","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Continuing Cardiology Education","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cce2.18","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Left atrial appendage occlusion (LAAO) is a promising alternative to oral anti-coagulation in patients with non-valvular atrial fibrillation. Recently, four-year results of PROTECT-AF demonstrated superiority of LAAO in all-cause mortality and stroke reduction compared to optimal medical treatment with warfarin. In this new era, it is important to identify the patients who would benefit more from LAAO and offer them priority for treatment.

Answer questions and earn CME: https://wileyhealthlearning.com/Activity2/4193475/Activity.aspx

Abstract Image

心房颤动患者左心耳闭塞预防脑卒中:适应症多样性和未来展望
对于非瓣膜性心房颤动患者,左心耳闭塞治疗(LAAO)是替代口服抗凝治疗的一种很有前景的方法。最近,PROTECT-AF的四年结果表明,与华法林最佳药物治疗相比,LAAO在全因死亡率和卒中减少方面具有优势。在这个新时代,重要的是确定哪些患者将从LAAO中获益更多,并为他们提供优先治疗。回答问题并获得CME: https://wileyhealthlearning.com/Activity2/4193475/Activity.aspx
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信